We are live on
!
Find out more
Mirae Asset Global Investments Portfolio holdings
AUM
$67.7B
1-Year Est. Return
57.61%
This Fund
S&P 500
This Quarter
Est. Return
-4.27%
1 Year Est. Return
+57.61%
3 Year Est. Return
+150.9%
5 Year Est. Return
+201.56%
10 Year Est. Return
+1,018.7%
AUM
$24.5B
AUM Growth
-$123M
(-0.5%)
Cap. Flow
+$15.2B
Cap. Flow
% of AUM
62.04%
Top 10 Holdings %
Top 10 Hldgs %
35.31%
Holding
1,687
New
95
Increased
1,038
Reduced
411
Closed
99
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Pinduoduo
PDD
|
+$4.51B |
| 2 |
MakeMyTrip
MMYT
|
+$2.46B |
| 3 |
Trip.com Group
TCOM
|
+$797M |
| 4 |
Yum China
YUMC
|
+$544M |
| 5 |
Alibaba
BABA
|
+$490M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
State Street SPDR S&P 500 ETF Trust
SPY
|
+$88.7M |
| 2 |
Pfizer
PFE
|
+$81.1M |
| 3 |
Blackrock
BLK
|
+$71.8M |
| 4 |
US Bancorp
USB
|
+$51.4M |
| 5 |
Invesco QQQ Trust
QQQ
|
+$33.6M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 31.26% |
| 2 | Consumer Discretionary | 9.29% |
| 3 | Communication Services | 9.15% |
| 4 | Healthcare | 7.13% |
| 5 | Financials | 5.76% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
1476
Alpha Teknova
TKNO
$395M
| $9.29K | ﹤0.01% |
1,784
+8
| +0.5% | +$59 |
|
1477
Vanda Pharmaceuticals
VNDA
$307M
| $9.15K | ﹤0.01% |
1,951
+8
| +0.4% | +$37 |
|
1478
Zillow
ZG
$7.89B
| $9.07K | ﹤0.01% |
135
+2
| +2% | +$148 |
|
1479
MaxCyte
MXCT
$161M
| $9.05K | ﹤0.01% |
3,314
-201
| -6% | -$792 |
|
|
ALMS
1480
Alumis Inc
ALMS
$3.21B
| $8.91K | ﹤0.01% |
1,580
+6
| +0.4% | +$35 |
|
|
CBL
1481
CBL Properties
CBL
$1.76B
| $8.84K | ﹤0.01% |
332
-11
| -3% | -$323 |
|
|
SLRN
1482
DELISTED
ACELYRIN
SLRN
| $8.76K | ﹤0.01% |
3,370
+27
| +0.8% | +$64 |
|
1483
OmniAb
OABI
$506M
| $8.76K | ﹤0.01% |
3,619
-414
| -10% | -$1.35K |
|
1484
Prime Medicine
PRME
$577M
| $8.73K | ﹤0.01% |
4,389
+18
| +0.4% | +$46 |
|
|
TSVT
1485
DELISTED
2seventy bio
TSVT
| $8.54K | ﹤0.01% |
1,726
+7
| +0.4% | +$22 |
|
|
TERN
1486
DELISTED
Terns Pharmaceuticals
TERN
| $8.3K | ﹤0.01% |
2,842
+12
| +0.4% | +$49 |
|
1487
Atea Pharmaceuticals
AVIR
$418M
| $8.28K | ﹤0.01% |
2,826
+11
| +0.4% | +$34 |
|
1488
Humacyte
HUMA
$162M
| $8.11K | ﹤0.01% |
4,136
-152
| -4% | -$571 |
|
1489
Annexon
ANNX
$873M
| $8.03K | ﹤0.01% |
3,567
+15
| +0.4% | +$50 |
|
1490
Design Therapeutics
DSGN
$916M
| $7.98K | ﹤0.01% |
1,895
+8
| +0.4% | +$38 |
|
|
CAN
1491
Canaan Creative
CAN
$150M
| $7.93K | ﹤0.01% |
8,708
+526
| +6% | +$836 |
|
1492
Codexis
CDXS
$178M
| $7.79K | ﹤0.01% |
2,772
+60
| +2% | +$233 |
|
1493
Ironwood Pharmaceuticals
IRWD
$684M
| $7.75K | ﹤0.01% |
5,499
+166
| +3% | +$395 |
|
|
ITOS
1494
DELISTED
iTeos Therapeutics
ITOS
| $7.72K | ﹤0.01% |
1,222
+5
| +0.4% | +$37 |
|
|
YMAB
1495
DELISTED
Y-mAbs Therapeutics
YMAB
| $7.24K | ﹤0.01% |
1,505
+12
| +0.8% | +$70 |
|
1496
Neurogene
NGNE
$733M
| $7.13K | ﹤0.01% |
491
-4
| -0.8% | -$69 |
|
1497
Tevogen Inc. Common Stock
TVGN
$26.8M
| $7.03K | ﹤0.01% |
117
| – | – |
|
1498
Corvus Pharmaceuticals
CRVS
$1.28B
| $6.92K | ﹤0.01% |
2,048
-93
| -4% | -$438 |
|
1499
Lexicon Pharmaceuticals
LXRX
$1.05B
| $6.9K | ﹤0.01% |
12,096
+50
| +0.4% | +$32 |
|
1500
Inhibrx
INBX
$1.46B
| $6.89K | ﹤0.01% |
488
+6
| +1% | +$81 |
|
Similar funds
Mirae Asset Global Investments's Q1 2025 Portfolio in Review
As of Q1 2025, Mirae Asset Global Investments held 1,687 positions worth $24.5B, down 0.5% from $24.6B the previous quarter. Its ten largest holdings account for 35% of the portfolio.
Mirae Asset Global Investments deployed $15.2B of net new capital in Q1 2025, opening 95 new positions and adding to 1,038 existing holdings. Its largest new stake was State Street SPDR Portfolio S&P 500 Value ETF: 320,000 shares worth $16.3M.
By sector, the portfolio is most concentrated in Technology at 31% of assets, down from 33% a quarter earlier, followed by Consumer Discretionary and Communication Services.
On the sell side, the largest reduction was State Street SPDR S&P 500 ETF Trust, an estimated $88.7M trimmed.
- Mirae Asset Global Investments's largest Q1 2025 buy was State Street SPDR Portfolio S&P 500 Value ETF: 320,000 shares worth $16.3M.
- Mirae Asset Global Investments added most to Pinduoduo in Q1 2025, an estimated $4.51B increase.
- Mirae Asset Global Investments's biggest Q1 2025 reduction was State Street SPDR S&P 500 ETF Trust, cutting an estimated $88.7M.
- Mirae Asset Global Investments fully exited State Street Utilities Select Sector SPDR ETF in Q1 2025, selling an estimated $8.71M.
- Mirae Asset Global Investments's ten largest holdings make up 35% of its $24.5B portfolio in Q1 2025.
- Mirae Asset Global Investments opened 95 new positions and closed 99 in Q1 2025.
- Mirae Asset Global Investments's portfolio value fell 0.5% quarter-over-quarter to $24.5B.
Based on Mirae Asset Global Investments's 13F filing for Q1 2025, filed 24 Apr 2025.